Liquid nimodipine compositions
Liquid compositions comprising nimodipine having improved nimodipine concentrations are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the liquid compositions of the present invention are also detailed herein.
1. A liquid composition comprising nimodipine and a solvent system from about 50% to about 97% (w/v) polyethylene glycol (PEG), about 1% to about 10% (w/v) water, from about 0.5% to about 5% (w/v) ethanol, and optionally from about 1% to about 50% (w/v) glycerin, wherein the concentration of nimodipine is about 6 mg/mL or about 12 mg/mL, and wherein about 5% or less nimodipine degradation is observed over a period of at least six months when exposed to 40° C. and 75% relative humidity.
2. The liquid composition of claim 1 , wherein the solvent system consists of PEG, water, and ethanol.
3. The liquid composition of claim 1 , wherein the solvent system consists of PEG, water, ethanol, and glycerin.
4. The liquid composition of claim 1 , wherein the solvent system comprises from about 65% to about 97% (w/v) PEG.
5. The liquid composition of claim 1 , wherein the solvent system comprises about 10% (w/v) water.
6. The liquid composition of claim 1 , wherein the solvent system comprises from about 1% to about 5% (w/v) ethanol.
7. The liquid composition of claim 1 , wherein the solvent system does not comprise glycerin.
8. The liquid composition of claim 1 , wherein the solvent system comprises from about 5% (w/v) ethanol.
9. The liquid composition of claim 1 , wherein the solvent system comprises from about 75% to about 90% (w/v) PEG.
10. The liquid composition of claim 1 , wherein nimodipine is present in an amount of about 60 mg per dosage unit.